Insider Transactions in Q2 2023 at Viridian Therapeutics, Inc.\De (VRDN)
Insider Transaction List (Q2 2023)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 16
2023
|
Lara Meisner Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
27
-0.09%
|
$756
$28.35 P/Share
|
Jun 16
2023
|
Lara Meisner Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
27
+0.09%
|
$621
$23.03 P/Share
|
Jun 15
2023
|
Lara Meisner Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,269
-7.04%
|
$63,532
$28.02 P/Share
|
Jun 15
2023
|
Lara Meisner Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,269
+6.58%
|
$52,187
$23.03 P/Share
|
Jun 06
2023
|
Lara Meisner Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
5,126
-14.61%
|
$128,150
$25.02 P/Share
|
Jun 06
2023
|
Lara Meisner Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,126
+12.74%
|
$92,268
$18.51 P/Share
|
Jun 05
2023
|
Lara Meisner Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
499
-1.64%
|
$12,475
$25.03 P/Share
|
Jun 05
2023
|
Lara Meisner Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
499
+1.61%
|
$8,982
$18.51 P/Share
|
Jun 02
2023
|
Lara Meisner Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,875
-5.89%
|
$45,000
$24.21 P/Share
|
Jun 02
2023
|
Lara Meisner Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,875
+5.56%
|
$26,250
$14.0 P/Share
|
Apr 12
2023
|
Scott Dunseth Myers Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
4,000
+1.52%
|
$100,000
$25.37 P/Share
|